Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002002426 | SCV002228710 | pathogenic | Mucopolysaccharidosis, MPS-IV-A | 2024-02-12 | criteria provided, single submitter | clinical testing | This sequence change affects the initiator methionine of the GALNS mRNA. The next in-frame methionine is located at codon 22. This variant is present in population databases (rs771531650, gnomAD 0.005%). Disruption of the initiator codon has been observed in individual(s) with mucopolysaccharidosis IVA (PMID: 15241807). ClinVar contains an entry for this variant (Variation ID: 1453466). Studies have shown that disruption of the initiator codon alters GALNS gene expression (PMID: 15241807). For these reasons, this variant has been classified as Pathogenic. |